Shaalan Beg, Vice President, Oncology at Science 37, shared a post on X:
“This will be an exciting ASCO24 for GI cancers. Mohamed E. Salem and I review a few trials in the ASCO Daily News podcast, specifically two CAR-T cell trials that are demonstrating clinical activity in GI cancers.
Look forward to seeing everyone in Chicago this weekend.”
Source: Shaalan Beg/X